Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC efficacy, safety, and immunogenicity study in adolescents and adults in TB-endemic regions
PACTR202409713966022Phase 2Unknown
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Sep 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 3
01
Overview
Phase 2 trial of mtbvac in Tuberculosis (TB) (2 arms), sponsored by International AIDS Vaccine Initiative. Status: unknown.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202409713966022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409713966022.